Association of Clinical Trials Organizations (ACTO) –
non-commercial organization of the companies/ legal entities and clinical research community engaged in clinical trials in Russia.
December, 13 2018
Annual General Meeting of Association of Clinical Trials Organizations (ACTO) was held
The meeting participants approved 2018 Annual Report of ACTO and priority areas of activity for 2019.
Executive Director Svetlana Zavidova made a presentation on the annual results of ACTO.
The election of the Board members took place. There was only one change, Olga Melnik from Novartis took over from Natalia Savitskaya. There is updated list of the Board members elected for 2019:
Leonid Dzivinsky (PRA),
Maria Nassonova (Almedis),
Peter Kosminsky (Janssen),
Olga Melnik (Novartis),
Anna Filimonova (Parexel),
Marina Filippova (PSI),
Svetlana Zavidova (by virtue of her position).
The participants discussed the types of agreements with the PIs (presentation of Maria Nassonova, Almedis), problems of biomedical cell product trials (presentation of Viola Yermakova, ACTO) and other relevant industry issues.